Holocene Advisors
EVH icon

Holocene Advisors’s Evolent Health EVH Stock Holding History

Holocene Advisors’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-527,943
Closed -$5.94M – 805
2025
Q2 		$5.94M Buy
+527,943
New +$4.85M 0.01% 347
2025
Q1 		– Sell
-611,556
Closed -$6.88M – 786
2024
Q4 		$6.88M Sell
611,556
-1,433,050
-70% -$25.2M 0.02% 339
2024
Q3 		$57.8M Sell
2,044,606
-1,031,121
-34% -$26.6M 0.23% 128
2024
Q2 		$58.8M Sell
3,075,727
-115,576
-4% -$2.95M 0.25% 124
2024
Q1 		$105M Buy
3,191,303
+393,412
+14% +$12.6M 0.38% 87
2023
Q4 		$92.4M Buy
2,797,891
+510,792
+22% +$14.5M 0.36% 96
2023
Q3 		$62.3M Buy
2,287,099
+338,474
+17% +$9.41M 0.27% 116
2023
Q2 		$59M Buy
1,948,625
+354,872
+22% +$11.5M 0.25% 120
2023
Q1 		$51.7M Buy
1,593,753
+32,400
+2% +$1.02M 0.25% 129
2022
Q4 		$43.8M Buy
+1,561,353
New +$44.8M 0.27% 116

Other funds holding EVH

CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Holocene Advisors's EVH Position: Q3 2025 in Review

Holocene Advisors sold out of Evolent Health (EVH) in Q3 2025, closing a stake of 527,943 shares — an estimated $5.94M sold.

Holocene Advisors first reported a position in EVH in Q4 2022 and held it in 10 quarters. The position peaked at $105M in Q1 2024. 240 funds tracked by Wall St. Rank hold EVH as of Q3 2025.

  • Holocene Advisors reported no remaining Evolent Health position as of Q3 2025 after selling out during the quarter.
  • Holocene Advisors sold 527,943 Evolent Health shares in Q3 2025, an estimated $5.94M.
  • Holocene Advisors first reported a position in Evolent Health in Q4 2022 and held it in 10 quarters.
  • Holocene Advisors's Evolent Health position peaked at $105M in Q1 2024.
  • 240 funds tracked by Wall St. Rank held Evolent Health as of Q3 2025.

Based on Holocene Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.